Stonebridge Capital Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,000
Closed -$21K 777
2020
Q1
$21K Hold
2,000
﹤0.01% 371
2019
Q4
$36K Sell
2,000
-1,000
-33% -$14.8K 0.01% 363
2019
Q3
$37K Hold
3,000
0.01% 361
2019
Q2
$59K Buy
+3,000
New +$64.2K 0.01% 298

Other funds holding AXGN

Stonebridge Capital Advisors's AXGN Position: Q2 2020 in Review

Stonebridge Capital Advisors sold out of Axogen (AXGN) in Q2 2020, closing a stake of 2,000 shares — an estimated $21K sold.

Stonebridge Capital Advisors first reported a position in AXGN in Q2 2019 and held it in 4 quarters. The position peaked at $59K in Q2 2019. 114 funds tracked by Wall St. Rank hold AXGN as of Q2 2020.

  • Stonebridge Capital Advisors reported no remaining Axogen position as of Q2 2020 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 2,000 Axogen shares in Q2 2020, an estimated $21K.
  • Stonebridge Capital Advisors first reported a position in Axogen in Q2 2019 and held it in 4 quarters.
  • Stonebridge Capital Advisors's Axogen position peaked at $59K in Q2 2019.
  • 114 funds tracked by Wall St. Rank held Axogen as of Q2 2020.

Based on Stonebridge Capital Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.